Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

NCT04644250 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab
DRUG: Paclitaxel liposome/Carboplatin
RADIATION: Intensity-modulated radiotherapy

Sponsor

Wei Ren